Bain Capital Life Sciences Investors’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio NAMSW Stock Details NAMSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2M	Hold	99,999	–	–	0.18%	20
2025 Q4	$2.3M	Sell	99,999 -1	-0%	-$25	0.18%	19
2025 Q3	$1.71M	Hold	100,000	–	–	0.11%	21
2025 Q2	$800K	Hold	100,000	–	–	0.1%	23
2025 Q1	$899K	Hold	100,000	–	–	0.13%	24
2024 Q4	$1.43M	Hold	100,000	–	–	0.17%	24
2024 Q3	$700K	Hold	100,000	–	–	0.07%	24
2024 Q2	$872K	Hold	100,000	–	–	0.1%	25
2024 Q1	$1.1M	Hold	100,000	–	–	0.09%	26
2023 Q4	$313K	Hold	100,000	–	–	0.03%	27
2023 Q3	$190K	Hold	100,000	–	–	0.02%	30
2023 Q2	$209K	Hold	100,000	–	–	0.02%	32
2023 Q1	$184K	Hold	100,000	–	–	0.02%	34
2022 Q4	$86K	Buy	+100,000	New	+$82.3K	0.01%	33

Other funds holding NAMSW

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bain Capital Life Sciences Investors's NAMSW Position: Q1 2026 in Review

Bain Capital Life Sciences Investors held its NewAmsterdam Pharma Warrant (NAMSW) position steady in Q1 2026 at 99,999 shares worth $2M. The position accounts for 0.18% of the portfolio, ranked #20.

Bain Capital Life Sciences Investors first reported a position in NAMSW in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.3M in Q4 2025. 9 funds tracked by Wall St. Rank hold NAMSW as of Q1 2026.

Bain Capital Life Sciences Investors held 99,999 shares of NewAmsterdam Pharma Warrant worth $2M as of Q1 2026.
Bain Capital Life Sciences Investors left its NewAmsterdam Pharma Warrant share count unchanged in Q1 2026.
NewAmsterdam Pharma Warrant made up 0.18% of Bain Capital Life Sciences Investors's portfolio in Q1 2026, its #20 holding.
Bain Capital Life Sciences Investors first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and has held it in 14 quarters since.
Bain Capital Life Sciences Investors's NewAmsterdam Pharma Warrant position peaked at $2.3M in Q4 2025.
9 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2026.

Based on Bain Capital Life Sciences Investors's 13F filing for Q1 2026, filed 15 May 2026.